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Interaction of native and oxidized Iipoprotein(a) with human mesangial
cells and matrix. The trapping of apolipoprotein(a) and apolipoprotein
B-100 in glomeruli of patients with the nephrotic syndrome seems to be
linked to a less favorable course of renal disease. To evaluate the potential
role of lipoprotein(a) as a mediator of glomerular injury, we measured
uptake of native lipoprotein(a) [Lp(a)] and oxidatively modified Lp(a) by
cultured human mesangial cells and matrix and studied the effects of Lp(a)
on mesangial cell DNA-synthesis and cellular proliferation. Uptake of
Lp(a) by mesangial cells occurred at a significantly lower affinity (1cD 16
sgIml vs. 39 jrg/ml) and a lower maximum degradative capacity (6.7-fold)
than for LDL. Specificity of receptor mediated uptake was 50% for Lp(a)
compared to 84% for LDL. Oxidative modification of both Lp(a) and
LDL was accompanied by a significant decrease in uptake and degradative
capacities. Due to the limited uptake, native and oxidatively modified
Lp(a) had only marginal effects on intracellular cholesterol metabolism,
which was measured as inhibition of sterol synthesis and stimulation of
cholesterol esterification. However, binding of Lp(a), oxidized Lp(a) and
oxidized LDL to extracellular mesangial matrix was enhanced compared
to LDL. Furthermore, incubation of mesangial cells with Lp(a) and
oxLp(a) in concentrations of 2.5 rg/ml and higher resulted in a decrease
of DNA synthesis. Regardless of the oxidative status, a maximal suppres-
sion of DNA synthesis was observed at 20 tg/ml Lp(a). Native Lp(a) also
blunted the stimulatoiy effects of PDGF on mesangial cell DNA-synthesis.
Lp(a) did not alter basal TGF-f3 transcription in human mesangial cells.
The avid interaction of Lp(a) and modified lipoproteins with mesangial
matrix provides a concept for the enhanced entrapment of these lipopro-
teins in the diseased glomerulum. Native Lp(a) is a poor ligand for the
LDL receptor; oxidation of Lp(a) even lowers the affinity towards this
receptor. Further studies must be carried out to clarify the pathophysio-
logical significance of Lp(a) trapping in the mesangial matrix.
Dyslipidemia is a common feature of the nephrotic syndrome
and is thought to promote the progression of renal disease. In
addition to the increase of LDL cholesterol, markedly elevated
levels of the atherogenic plasma lipoprotein Lp(a) have also been
identified in patients with the nephrotic syndrome [1, 21. In the
general population high levels of Lp(a) are considered to be an
even stronger predictor for premature atherosclerosis than levels
of LDL, and thus to be an independent discriminating risk factor
for premature atherosclerotic vascular disease [3]. Like LDL,
Lp(a) deposits have been identified in coronaiy vessels [4] and
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they may also undergo oxidative modification. Analysis of scarred
glomeruli from various forms of renal disease display features
similar to those found in atherosclerosis such that common
pathophysiological pathways have been postulated [5]. The pres-
ence of Lp(a) deposits within the kidney seems also be associated
with a less favorable course of renal disease, a higher prevalence
of glomerulosclerosis and interstitial disease, as well as more
severe proteinuria [6]. However, it remains unclear whether
glomerular deposition of Lp(a) requires receptor mediated path-
ways, and how specific cellular uptake and deposition occurs.
Since apoB-100 is the main protein component of the Lp(a)
particle [7], it has been speculated that the LDL receptor may be
involved in its clearance. Binding of Lp(a) to the LDL-receptor
has been reported in fibroblasts and hepatic tissue, although it
occurred to a significantly lesser degree than did LDL [7—10].
Human mesangial cells possess LDL receptors capable of specific
and high affinity uptake of apoB- and apoE-containing lipopro-
teins [11]. Studies of Coritsidis et al [12] and Wheeler et al [13]
using rat mesangial cells provide evidence for the presence of
scavenger receptors which lead to preferential uptake of modified,
that is, glycosylated or oxidized LDL. Furthermore, modified
lipoproteins may also bind to extracellular matrix components
[12].
Therefore, we evaluated this current hypothesis and studied
binding and degradation of native and oxidized Lp(a) by human
mesangial cells in culture and compared its effect with native and
oxidized LDL. Since Lp(a) has been shown to promote prolifer-
ation in human smooth muscle cells, we evaluated the effect of
Lp(a) on inducing growth associated phenomena such as DNA
synthesis and cellular proliferation.
Methods
Cell cultures
Human mesangial cells came from patients undergoing tumor
nephrectomy and glomeruli were isolated by sieving technique as
previously described [14]. Glomerular cores were then suspended
in RPMI 1640 medium with 10% FCS, L-glutamine 2.5 mtvi,
sodium pyruvate 0.1 m, penicillin io U/liter, streptomycin 100
mg/liter, non-essential amino acids 0.2% (all Seromed, Berlin,
Germany) and a supplement containing insulin, transferrin, and
sodium-selenite (Boehringer-Mannheim, Germany). Glomeruli
were plated onto Petri dishes (Greiner, Nurtingen, Germany) at a
concentration of 100 glomeruli/cm2. Approximately in the third
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week of primary culture, mesangial cells began to spread around
the glomeruli. After residual epithelial cells had been excised with
a scalpel, mesangial cells were subcultured. Fibroblast contami-
nation was excluded by growing the cells for two weeks in a
L-valine free medium [15]. Cells from passage five to twelve were
used for all experiments.
Morphologic and immunochemical studies
Mesangial cells in culture were identified with phase-contrast
microscopy. All cell lines showed the morphological and immu-
nological characteristics as described by Lovett, Ryan and Sterzel
[16]. Immunochemical characterization was performed using the
peroxidase-antiperoxidase (PAP) method according to Bross et al
[17] with modifications previously described [18]. Antibodies for
factor VIII did not stain, thus excluding contamination with
endothelial cells. Cells were homogenously positive for smooth
muscle alpha actin and vimcntin, but were negative for cytokera-
tin, thus excluding epithelial cells.
Generation of mesangial matrix
Cells were grown for two weeks in 35 mm tissue culture plates.
After removal of media, the cell layer was dissociated from the
matrix by incubation with 0,25 mi NH4OH/0.i% Triton X for
eight minutes, followed by three washes with PBS and a final wash
with water. Insoluble matrix remained in the tissue culture wells
[19]. As determined by Lowry method, extraeellular matrix pro-
tein contributed about 25% to the total protein content per well.
Characterization of laminin, fibroneetin and collagen IV as major
matrix components was performed by immunochemical staining
as described [19].
Isolation of Lp(a) and LDL
Human LDL was isolated by sequential ultracentrifugation and
stored at 4°C as described recently [11]. For Lp(a)-isolation, Lp(a)
enriched regeneration fluid was obtained from a LDL-apheresis
system based on heparin induced extracorporeal LDL-preeipita-
tion (H.E.L.P.; Braun Melsungen, Melsungen, Germany) [20].
The regenerate fluid was ultracentrifuged first at a density of 1.065
kg/liter, then at 1.120 kg/liter, and then subjected to density
gradient ultracentrifugation. Finally Lp(a) was purified using
sephadex G-25M gel chromatography and lysine-sepharose 4B
chromatography, and dialyzed extensively against 154 mM NaCI, 1
mM EDTA (pH 7.4).
Purification and characterization of Lp(a)
Homogeneity and stability of lipoproteins was tested frequently
by agarose gel electrophoresis (REP-HDL-plus cholesterol elec-
trophoresis, Helena Diagnostika, Hartheim, Germany).
Native Lp(a) was found to migrate in the pre-beta region and
was free of LDL, VLDL and HDL protein contamination. To
further define which part of the protein moiety of Lp(a) is affected
by oxidation, sodium dodecyl sulfate-polyaerylamide gradient gel
electrophoresis (SDS-PAGE) was performed using a 5 to 10%
gradient gel at a constant current of 50 mA in a vertical electro-
phoresis chamber (Miniprotean II; Biorad, Munich, Germany).
Staining was done using coomassie blue and proteins of known
molecular weight were used as standard.
Two hundred microliters of Lp(a) (0.5 mg protein/ml) were
applied before and after oxidation to a 300 mm Superose 6
column equilibrated with 100 mmol/liter Na2HPO4, pH 7.4, and
200 mmol/liter NaCI. To exclude aggregation and to confirm
purity of the Lp(a) preparation fast lipoprotein chromatography
was performed with a chromatography system from Pharmacia
(Uppsala, Sweden) according to the method of März et al [211.
The eluent flow rate was 500 pA/mm. Lipoproteins were detected
on-line at 280 nm. One milliliter fractions were collected and
analyzed for Lp(a) concentration using a turbidimetrie assay
(Greiner, NUrtingen, Germany).
Oxidation of Lp(a) and LDL
Lp(a) was oxidized in a similar fashion as LDL described
recently [22]. Briefly, antioxidant-free LDL or Lp(a) (0.3 mg
protein/mi) were incubated with CuSO4 (5 bLM) in phosphate
buffered saline for 24 hours at room temperature. The degree of
oxidation was quantified by two different methods: (i) the increase
in relative mobility on agarose gel, indicating an enhanced nega-
tive charge of oxidized lipoprotein; (ii) the formation of thiobar-
biturie acid-reactive substances (TBARS) [23]. Lp(a) was stored
at room temperature in the dark because of the tendency of low
molecular weight Lp(a) to form a gel by self-association in the
cold. Lipoproteins were prepared fresh every two weeks.
Apo(a) immunoblotting
Apo(a) isoform determination was performed on serum using a
modification of a previously described sensitive immunoblotting
technique [24]. Briefly, serum was added to a solution containing
75% glycerol, 0.5% bromophenol blue, and 10% SDS, and was
applied to 4% polyacrylamide eleetrophoresis gel. Gels were run
on the Phast System (Pharmacia, Uppsala, Sweden) for approxi-
mately 0.5 hours at 60 mA. After transfer of the proteins to
Immobilion-polyvinylidene-difluoride transfer membrane (Milli-
pore, Bedford, MA, USA), incubation of the membranes with
antibodies was performed using an anti-apo(a) monoelonal anti-
body (4F3; 1:2,000; Cappel, Durham, NC, USA) as first antibody
and the Vectastain ABC antimouse IgG test kit (Vector Labora-
tories, Burlingame, CA, USA) for detection. A standard of a
defined isoform pool (F, Si, S3, S4, > S4) was used on the gel
(Immuno, Vienna, Austria) [25]. The two isoforms of the patient
were larger than apoB-100 and did migrate in the approximate
position of S1/S2 compared with the standard.
Preparation of lipoprotein deficient serum (LDS)
Human plasma was rendered lipoprotein deficient by a two step
ultracentrifugation procedure (150,000 X g for 48 hr at 10°C),
adjusting the plasma to density = 1,250 g/ml by addition of KBr.
After removal of all lipoprotein fractions, LDS was dialyzed
against 154 mM NaCI, 250 mM EDTA, 5 mrvi HEPES pH 7.4,
heat-inactivated at 54°C for one hour and sterilized by filtration
through a 45 rm Millipore membrane. Protein content was
adjusted to 40 mg/mi.
Radioiodination of lipoproteins
Radioiodination of Lp(a) and LDL was performed by the
method of McFarlane [26] modified for lipoproteins by Bilheimer,
Eisenberg and Levy [27]. The final preparations of 1251-labeled
lipoproteins were filter-sterilized and used within two weeks.
Assay for binding, internalization and degradation of lipoproteins
To induce maximal apoB,E receptor activity, mesangial cells
were incubated in 10% LDS containing medium. After 48 hours,
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Fig. 1. Sodium dodecyl sulfate-polyaciylamide gradient gel electrophoresis
(5 to 10%) showing native Lp(a) (lane 4) and Lp(a) during various time
points of oxidation (lane 3, 12 hr; lane 2, 24 hr; lane 1, 48 hr). S denotes the
standard. ApoB-l0O and apo(a) were identified by immunoblot (data not
shown).
LDS containing medium was replaced and 1251-labeled lipopro-
teins with or without a 25-fold excess of unlabeled lipoproteins
were added. The cultures were incubated for five hours at 37°C.
The medium was removed and the cells were placed on ice. The
culture dishes were then washed five times with a cold buffer
containing 154 mivi NaCl, 50 mivi Tris (pH 7.4) and 2 mg/mi bovine
fatty acid free serum albumin and assays for binding, internaliza-
tion and degradation were performed by standard methods [11].
The heparin releasable activity represents binding at 37°C. After
the release of cell surface bound activity by heparin, monolayers
were dissolved in 1 ml of 0.1 N NaOH and radioactivity and
protein was measured. The radioactivity in the pellet was taken as
a measure for internalization. Non-iodide trichloroacetic acid
(TCA)-soluble radioactivity served as a measure for lipoprotein
degradation. Nonspecific binding, internalization and degradation
was defined as amount of the lipoprotein taken up in the presence
of 25-fold excess of unlabeled ligand. All experiments were
performed in triplicate.
To study the binding of lipoproteins to mesangial cell matrix,
cellular matrix was prepared and incubated with increasing con-
centrations of LDL, oxidized LDL, Lp(a) and oxidized Lp(a) for
two hours at 4°C. The culture dishes were then washed five times
with a cold buffer containing 154 ms NaC1, 50 msi Tris (pH 7.4)
and 2 mg/mi bovine fatty acid free serum albumin. Matrix was
then solubilized with 0.1 M NaOH. Radioactivity and protein
content was measured as described above.
Cellular sterol synthesis and cholesterol esterification
Cell cultures were incubated in DMEM containing 10% LDS
for 48 hours and thereafter with varying concentrations of lipopro-
teins for 12 hours. Incorporation of ['4C] acetate into sterols was
used to determine cellular sterol synthesis as described [111.
Cellular cholesterol esterification was performed as described
elsewhere [11]. All experiments were performed in duplicate.
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Fig. 2. Fast lipoprotein chromatography demonstrating a representative elu-
tion profile of native Lp(a) particles (S). Lp(a) was determined directly in
the various fractions obtained using the turbidimetric assay described in
Methods (0). Each circle represents a measurement in a single fraction (1
ml). Elution peaks of VLDL, LDL and HDL obtained at different
retention times and identified in separate experiments are indicated by the
arrows.
Cell proliferation studies
Measurement of DNA synthesis. DNA synthesis in mesangial
cells was evaluated by measuring [3HJ-thymidine uptake. Cells
were grown to subconfluency in 96-well plates (15,000 cells/well)
and growth arrested with 0.5% FCS medium for 48 hours.
Subsequently, cells were incubated for 24 hours in the presence of
Lp(a) and {3Hj-thymidine (37 kBq/ml). Cells were washed twice
with PBS and then incubated with TCA (0.5%) at 4°C for 60
minutes. TCA supernatants, containing soluble protein, were
removed by pipetting. Well-adherent DNA was dissolved by
incubation with NaOH (0.5 N) at 37°C for 60 minutes. The NaOH
solution was neutralized with NaOH/TCA mix, transferred to vials
containing scintillation fluid and counted in a /3-scintillation
counter. Uptake of thymidine by cells grown in lipoprotein
supplemented media was expressed as a percentage of incorpo-
ration by control cells grown in RPM! 1640 media without a
growth stimulus under identical conditions. Each experiment was
performed in replicate.
Measurement of cell proliferation. The number of viable cells per
well was assessed with a tetrazolium based nonradioactive prolif-
eration assay (Cell Titer 96, Promega, Heidelberg, Germany), as
reported previously [28]. Briefly, cells were grown at a density of
15,000 cells per well in 96-well culture plates. After growth
inhibition in 0.5% FCS media for 48 hours a lipoprotein contain-
ing solution or an equal amount of media was added and cells
were incubated for 72 hours. Then, tetrazolium was added and
cells were further incubated for four hours at 37°C. The conver-
sion of tetrazolium to formazan by viable cells causes a change for
light absorption at 570 nm. A linear relationship between cell
number and change for light adsorption at 570 nm was detected
for cell counts above 7,500 cells per well. (r2 = 0.989). Analysis of
variance revealed that the sensitivity of the assay allowed detec-
tion of a 20% difference in cell number per well. LDH release into
the media was measured as an additional parameter to assess cell
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toxic effects of Lp(a). LDH was measured on an autoanalyzer
used for clinical routine analysis. Total LDH content was mea-
sured after sonication of mesangial cells for five minutes.
Analysis of cellular TGF-/3 mRNA. The effect of Lp(a) on
TGF-f3 mRNA in human mesangial cells was studied by Northern
analysis of 10 xg of total RNA, following standard protocols as
previously described [29]. RNA was isolated from cells that had
been incubated in media containing 0.5% FCS Lp(a) 5 jxg/ml
for various amounts of time. A human 2.1 kb TGF-13 probe
encoding the complete coding sequence, was purchased from
ATCC [30]. The probe detected a 2.5 kb mRNA fragment in
human mesangial cells. To estimate the amount of specific mRNA
in a given sample, the intensity of the TGF-f3 band was quantified
by scanning densitometry and normalized to the intensity of the 28
s ribosomal RNA-band. Three independent experiments were
performed. Data were given as arbitrary density units.
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Table 1. Concentration dependent uptake of '1-1abeled LDL,
oxidized LDL, Lp(a) and oxidized Lp(a) by human mesangial cells
'251-Lipoprotein
LDL
Binding Internalization Degradation
Vng/mg 199 861 3,500
K0 pg/mI 21 15 13
Oxidized LDL
V,ng/mg 98 328 1,319
K0 pg/mi 73 81 44
Lp(a)
V,,ng/mg 112 157 525
K0 pg/mI 70 27 21
Oxidized Lp(a)
V,,, rig/mg 49 120 199
K0 p.g/ml 43
-__60 86
Statistical evaluation
Results are given as means SEM. Statistical analysis was
performed by paired or unpaired Student's I-test, as appropriate.
Analysis of variance was performed with a PC based statistical
software package (SigmaStat; Jandel GmbH, Erkrath, Germany).
Results
Characterization of Lp(a)
The relative mobility of the oxidized lipoproteins was enhanced
in a comparable manner, indicating that LDL and Lp(a) were
oxidized to a similar extent [20]. Levels of TBARS, determined in
samples containing 0.3 mg lipoprotein per ml, were 0.2 0.01 J.LM
for native LDL, 0.2 0.01 /LM for native Lp(a), 3.4 0.8 M for
oxidized LDL, and 4.8 1 fLM for oxidized Lp(a). Native and
oxidized Lp(a) were subjected to gradient SDS-polyacrylamide gel
electrophoresis (5 to 10%) in order to elucidate a possible
differential oxidation of apoproteins. In contrast to apoB-100
which showed a considerable fragmentation of its protein moiety,
apo(a) appears to be the more stable component with increasing
time of oxidation (Fig. 1). Electrophoresis further demonstrates
the purity of the Lp(a) preparation since apolipoproteins E, C
I-Ill and A-I, protein components of VLDL or HDL, are not
detected. To further exclude aggregation native and oxidized
Lp(a) were subjected to fast lipoprotein chromatography. Figure
2 demonstrates a representative elution profile of native Lp(a). It
has to be pointed out that no significant difference could be
detected between the elution profiles of native and oxidized
Lp(a). Therefore, this method confirmed the high purity of the
Lp(a) preparation and no contamination with VLDL, LDL or
HDL could be detected. In addition, no aggregation of Lp(a)
could be identified.
Cellular uptake of LDL and oxidized LDL
To determine whether human mesangial cells express receptors
for cellular uptake of oxidized LDL, various concentrations (5 to
100 jsg protein/mi) of '251-labeled LDL and oxidized LDL were
incubated with confluent monolayer cultures. Binding, internal-
ization and degradation of native LDL occurred in a saturable
manner with high affinity. In contrast, cellular uptake of oxidized
LDL was characterized by low affinity binding. Maximal uptake
and degradative capacity for oxidized LDL was only 29% of LDL
(Figs. 3 A-C). Scatchard plot analysis of binding kinetics revealed
markedly higher KD-values (as a measure of lower affinity) and
lower V,ax values (maximal capacities) for oxidized LDL com-
Table 2. Percentage of LDL-receptor mediated binding, internalization
and degradation of LDL, oxidized LDL, Lp(a) and oxidized Lp(a) by
human mesangial cells at 37°C
LDL
Oxidized
LDL Lp(a)
Oxidized
Lp(a)
Binding 76 4% 62 4% 42 6% 34 4%
Internalization 86 4% 55 13% 46 12% 35 2%
Degradation 91 1% 68 3% 64± 7% 39 5%
pared to LDL (Table 1). In addition, differences in uptake
specificity were noted: while LDL was taken up and degraded with
high specificity (Table 2, mean 84%), receptor mediated uptake of
oxidized LDL occurred with significant lower specificity (mean
61%).
Cellular uptake of Lp(a) and oxidized Lp(a)
Concentration dependent binding and internalization of Lp(a)
was almost linear and not saturable with a low specificity for
receptor mediated uptake (mean 5 1%). Uptake of oxidized Lp(a)
was even less specific (mean 36%). Analysis of the binding curves
by Scatchard plot method indicated that mesangial cells exhibited
a low affinity for Lp(a) with a dissociation constant (KD) of 39
jtg/ml medium and a low saturation (Vmax) at 525 g/mg cell
protein. In addition, the maximum amount of oxidized Lp(a)
taken up by receptor-mediated pathways was even lower
199 g/ml medium, Figs. 4 A-C).
Effect of LDL, Lp(a) and oxidized Lp(a) on cellular sterol
synthesis and cholesterol esterif 1 cation
Incorporation of ['4C] acetate into sterols. To determine the
influence of Lp(a) and oxidized Lp(a) on intracellular cholesterol
metabolism, mesangial cells were incubated with varying concen-
trations (1 to 10 sg protein/mi) of these lipoproteins. The
presence of LDL (10 .tg protein/ml) inhibited sterol synthesis by
76 3%. However, Lp(a) and oxidized Lp(a) did not significantly
suppress intracellular de novo sterol synthesis. Incubation with
Lp(a) or oxidized Lp(a) (10 sg/ml) inhibited sterol synthesis by
only 13 4.5% and 9 5.2%, respectively (Fig. SA).
[3HJ-oleate incorporation into cholesteiyl ester. Incorporation of
oleate into cholesteryl ester was used as a measure of effective
cellular lipoprotein uptake. Incubation of mesangial cells with
LDL did enhance cholesteryl esterification. Equal amounts of
Lp(a) had a much smaller influence on cholesterol ester forma-
tion rate (increase at 50 sg protein/ml medium 2.2-fold as
compared to 12-fold for LDL). Almost no cholesterol esterifica-
tion was observed when mesangial cells were incubated with
oxidized Lp(a) (Fig. 5B).
Binding of LDL, oxidized LDL, Lp(a) and oxidized Lp(a) to
mesangial matrix
Matrix generated by mesangial cells in 35 mm wells was about
40 sg of matrix protein (compared to 150 to 200 zg cell
protein/well). Concentration dependent binding of Lp(a), oxi-
dized Lp(a) and oxidized LDL to matrix was not saturable. Since
binding of lipoproteins to matrix was not inhibitable by excess
amounts of unlabeled lipoprotein, our results suggest that recep-
tor specific binding sites are not involved. Binding of LDL to
mesangial matrix did not occur at a significant rate (Fig. 6).
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Fig. S. Inhibition of cholesterol synthesis (A) and formation of cholesteiyl
esters (B) by LDL (Ei), Lp(a) (L;) and oxidized Lp(a) (fl) in human
mesangial cells. Cholesterol esterification is given as picomol [3H]-oleate
formed/mg cell protein/two hours. Data are given as mean of three
independent determinations. All measurements were carried out in
duplicate.
Cell proliferation studies
Effects of LDL on DNA synthesis. A stimulatoly effect of LDL
on DNA synthesis has been reported previously. The effects of
lipoproteins on mesangial cell DNA synthesis were determined by
[3H]-thymidine incorporation after 24 hours. At low concentrations
LDL increased DNA synthesis and a maximum effect was ob-
served at 5 xg/ml (P < 0.05 vs. control). At concentrations above
100 jxg/ml, LDL caused a significant suppression of DNA synthe-
sis (P < 0.05 vs. control; Fig. 7A).
Effects of Lp(a) and oxidized Lp(a) on DNA synthesis. As shown
in Figure 7B both Lp(a) and oxLp(a) caused a dose dependent
suppression of {3H]-thymidine incorporation into mesangial cells.
A maximal decrease in DNA-synthesis were observed at 20 g/ml
Lp(a) (P < 0.01 vs. control). At concentrations of 10 and 20
j.tg/ml, the suppressive effect of oxidized Lp(a) on DNA synthesis
were more pronounced compared to Lp(a) [P < 0.05 vs. Lp(a)].
To assess whether Lp(a) exerted toxic effects on mesangial cells,
LDH release into the culture media was measured. No significant
amount of LDH was released into the culture media even when
cells had been incubated for 24 and 48 hours [48 hr: Lp(a) 5
g/ml, 13 1 U/ml; 10 xgImi, 9 3 U/ml; 20 .tg/ml, 10 2 U/mi.
Total-LDH 196 4 U/mi; control cells 10 2 U/mI]. Concen-
trations of Lp(a) and oxidized Lp(a) above 50 g protein/ml
caused a partial detachment of the mesangiai cell layer from the
wells and were therefore considered as cytotoxic.
Cell viability after prolonged incubation of human mesangial cells
in media containing Lp(a). Since short-term incubation with Lp(a)
suppressed DNA synthesis, we investigated whether prolonged
incubation of mesangial cells in media containing Lp(a) reduced
the number of viable cells. Cell proliferation/toxicity assays were
performed after cells had been stimulated with Lp(a) and oxidized
Lp(a) for 72 hours. We could not detect a significant decrease in
cell number when cells were incubated in media containing up to
20 sg/ml Lp(a) or oxidized Lp(a) (Fig. 8). At concentrations of 50
xg/ml and higher, however, a detachment of mesangial cells from
the culture wells was visible after 72 hours, indicating cell death.
DNA-Synthesis in mesangial cells after Co-stimulation with
PDGF and Lp(a). Stimulation of mesangial cells with PDGF-BB
(2 and 20 ng/ml) resulted in a significant increase in DNA-
synthesis (P < 0.05 vs. control). Coincubation with Lp(a) (1
rg/mI) decreased the stimulatory effects of PDGF. The stimula-
tory effects of PDGF were completely blunted when mesangial
cells were coincubated with Lp(a) 2.5 sg/ml (Fig. 9).
Effect of Lp(a) on TGF-p mRNA levels. Mesangiai cells that had
been growth arrested for 48 hours demonstrated a basal expres-
sion of TGF-f3 mRNA that was not changed when cells were
incubated with Lp(a) 5 Lg/ml for up to 24 hours (Fig. 10 A, B).
Discussion
Glomerular deposits of Lp(a) are linked to a less favorable
course of renal disease [6]. It is not known whether Lp(a) deposits
just passively follow the course of renal disease or whether they
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Fig. 7. Effect of lipoproteins on DNA-synthesis. A. LDL; B. Lp(a) (El) and
oxLp(a) (n). [3H]-thymidine uptake into mesangial cells was measured
after 24 hours of incubation with varying concentrations of lipoprotein. At
least 5 independent experiments were performed for each concentration
in sixplicates. Data are given as cpm/welI (15,000 cells). A significant
decrease in thymidine uptake was detected for Lp(a) and oxidized Lp(a)
concentrations of 5 g/ml and higher (P < 0.01 vs. control).
contribute to glomerular injury. So far, it remains unclear whether
accumulation of Lp(a) is a result of specific, receptor-mediated
uptake or a consequence of entrapment by mesangial matrix
components. In addition, no data are available concerning the
effects of Lp(a) on glomerular cell function. Since Lp(a) is
structurally similar to LDL in that apoB-100 is the major apopro-
tein component, one might expect that catabolism of Lp(a) occurs
via the LDL-receptor mediated pathway. To date, studies address-
ing Lp(a)/LDL-receptor interaction have produced conflicting
results. Some evidence supports the concept that the LDL-
receptor mediates Lp(a) metabolism: Lp(a) can bind to the
LDL-receptor in fibroblasts [8, 9] and HepG2 [31] cells, and can
Lp(a), pg/mi
Fig. 8. Effect of Lp(a) (El) and oxidized Lp(a) () on cell viability. Cell
viability was assessed with a tetrazolium based cytotoxicity assay. Cell
viability was analyzed after 72 hours of incubation in media containing
0.5% FCS and varying amounts of lipopoteins as indicated. Data are given
from 6 experiments as percentage SEM of viable cells that were
incubated in media containing 0.5% FCS and no lipoproteins.
Control 0.2 2.0 20
PDGF, rig/mi
Fig. 9. Effect of Lp(a) on PDGF stimulated DNA-synthesis in mesangial
cells. [3H}-thymidine uptake into mesangial cells was measured after 24
hours of incubation with varying concentrations of PDGF-BB and lipopro-
tein as indicated. Symbols are: (El) no Lp(a); () Lp(a) 1 tg/ml; ()Lp(a)
2.5 g/ml. Control cells were incubated in media containing 0.5% FCS
without growth stimulus. Data are given as mean SEM of 4 experiments
for each concentration.
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be degraded by human macrophages [7]. Transgenic mice over-
expressing the LDL-receptor catabolized human Lp(a) much
faster than did control mice [32]. Patients with familial hypercho-
lesterolemia have been reported to have elevated Lp(a) levels
TGF-13
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Fig. 10. Effect of Lp(a) on expression of TGF-J3 mRNA in human mesan-
gial cells (A). Representative autoradiogram from Northern analysis of 10
tg of total RNA from human mesangial cells after different time periods
of incubation in media Lp(a) 5 jg/ml. Stimulated as well as unstimu-
lated cells expressed a 2.5 kb mRNA signal for TGF-3. To control for the
amount of total RNA, the 28S and 18S ribosomal RNA bands were
stained with ethidium bromide and photographed to demonstrate equal
loading and integrity of RNA. Quantitation of TGF-/3 mRNA expression
in human mesangial cells (B). TGF-f3 mRNA signals from three Northern
blots were analyzed by scanning densitometry. Data were corrected for the
relative density of the corresponding 28S ribosomal RNA signal. Symbols
are: (LI) —Lp(a) (); +Lp(a).
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[33]. Human mesangial cells possess apoB and apoE receptors for
high affinity binding of LDL [11]. Although preincubation of mesan-
gial cells in lipoprotein-deficient medium maximally up-regulates
LDL-receptor activity, binding, internalization and degradation of
native and oxidized Lp(a) by mesangial cells in our studies was of
low affinity, specificity and maximal capacity compared to the
uptake of native LDL. Therefore, a major finding of the present
investigation was that Lp(a) is a poor ligand for the LDL-receptor
0 4 8 24 hours
in human mesangial cells. Recently, in vivo studies performed in
patients with homozygous hypercholesterolemia who possess little
or no LDL-receptor activity stated that the LDL-receptor is not
required for normal catabolism of Lp(a) in humans [34].
Uptake of oxidized LDL is attributed to scavenger receptors
that have been identified on several cell types including human
monocyte-derived macrophages [35] and rabbit smooth muscle
cells [36]. Expression of scavenger receptors and uptake of
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oxidized LDL has been demonstrated in rat mesangial cells,
suggesting that intracellular lipid loading of mesangial cells, as it
has been demonstrated for macrophages [12, 37], might contrib-
ute to glomerular injuiy. Schlondorif [38] also suggested the
existence of scavenger receptors on human mesangial cells,
whereas other investigators could not detect binding sites for
oxidized or acetylated LDL [39]. A recent study by Lee and Koh
[401, who used electronmicroscopy technique to visualize binding
and uptake of gold labeled oxidized or acetylated LDL by
mesangial cells, failed to demonstrate a scavenger receptor-
mediated pathway [40]. In our homologous system, uptake of
oxidized Lp(a) as well as oxidized LDL by mesangial cells was
characterized by poor affinity that was even diminished compared
to that obtained for native Lp(a). Maximal degradative capacity
for oxidized lipoproteins was only 10 to 15% of maximal degra-
dative capacity for LDL. As expected from the limited uptake by
mesangial cells, native and oxidatively modified Lp(a) had only
marginal effects on intracellular cholesterol metabolism. The poor
uptake of oxidized lipoproteins by mesangial cells in our studies
supports the notion that mesangial cells do not express specific
receptors for the uptake of modified lipoproteins. Interestingly,
SDS-gel analysis of apoprotein integrity after Cu ++ oxidation
revealed that the apo(a) protein component remained relatively
intact and degradation occurred mainly at the apo B-100 moiety
[41]. This sheds some new light on the relevance of an intact apo
B-100 component for handling of Lp(a) by human mesangial cells.
Since the poor uptake of Lp(a) by human mesangial cells is
significantly diminished after Cu-oxidation, one has to con-
clude that the small fraction of Lp(a) taken up by the cells relies
on the presence of an intact apo B-100 protein.
While native LDL was only poorly bound to mesangial matrix,
its oxidized form displayed avid interactions with matrix proteins.
Lp(a) bound to a considerable extent to mesangial matrix, regard-
less of its oxidative status. Glomerular deposits of Lp(a), found in
various forms or renal disease, are therefore more likely to
represent matrix bound than internalized lipoprotein. To date,
one only can speculate by which mechanisms matrix bound
lipoproteins could contribute to glomerular injury. Lipoprotein-
matrix interactions seem to contribute to the generation of
atherosclerotic lesions. LDL and modified LDL bind to extracel-
lular matrix proteins of the vascular waIl [42] and proteoglycan-
lipprotein complexes have been extracted from atheromatous
lesions [43, 44]. The pathogenetic significance of matrix bound
Lp(a) in kidney disease could be as follows: Matrix bound Lp(a)
could enhance migration and adherence of leukocytes which in
turn could contribute to glomerular injury directly or through
oxidation of lipoproteins [45]. Alternatively, matrix bound li-
poproteins could interfere with cell-matrix interactions, thereby
inducing cell apoptosis [461.
Proliferation of mesangial cells is considered an important step
during the development of glomerular sclerosis [47]. In rat
mesangial cells, low concentrations of LDL induced a prolifera-
tive response [13, 48], whereas high concentrations suppressed
DNA-synthesis in that they were toxic to mesangial cells. Similar
results were obtained in studies with human mesangial cells where
low concentrations of LDL caused a moderate increase in DNA-
synthesis as well as an activation of early response genes c-fos and
c-jun. When cells were stimulated with PDGF or endothelin-1, the
activation of DNA-synthesis by LDL was even enhanced [39].
There are no studies addressing the influence of Lp(a) on human
mesangial cell proliferation. In keeping with earlier studies in rat
and human mesangial cell cultures, our data demonstrate en-
hanced DNA-synthesis when mesangial cells were stimulated with
low concentrations of LDL. We demonstrated no stimulatory, but
an inhibitory effect of native Lp(a) and oxidized Lp(a) on
DNA-synthesis. In concentrations below 50 .tg/ml, Lp(a) as well
as oxidized Lp(a) depressed DNA synthesis without visible signs
of cytotoxicity. Furthermore, low concentrations of Lp(a) inhib-
ited the stimulatory effects of PDGF on DNA-synthesis. These
findings leave open by which pathophysiological pathway Lp(a)
might contribute to the progression of glomerular disease. A
current hypothesis that is supported by several animal studies
claims that mesangial proliferation, followed by accumulation of
extracellular matrix proteins ultimately leads to the development
of glomerular sclerosis [47]. Inhibition of mesangial proliferation
could inhibit the progression of glomerular disease in these
studies. However, studies concerning the mechanisms of diabetic
nephropathy demonstrate that mesangial cell proliferation is not
a prerequisite for the development of subsequent glomerular
damage. Incubation of mesangial cells with high glucose leads to
a marked depression of cellular proliferation [49]. The generation
of excess extracellular matrix proteins in the glomeruli of diabetic
rats has been attributed to increased expression of TGF-13 [501.
Additional evidence for the role of TGF-/3 in the pathogenesis of
glomerular damage without mesangial proliferation was provided
by the studies of Isaka et al [51]. They induced glomulosclerosis in
rat kidneys by transfecting them with TGF-f3 mRNA. On a
cellular level, they could demonstrate growth inhibition without
cell death in mesangial cells. It therefore seemed attractive to
speculate whether the effects of Lp(a) on mesangial cell prolifer-
ation were mediated by changes in autocrine TGF-/3 production.
However, in our studies, a concentration of Lp(a) that was able to
suppress basal as well as PDGF-stimulated DNA synthesis had no
influence on autotranscription of TGF-p. We therefore did not
find evidence in support of the hypothesis that Lp(a) exerts its
negative effects on mesangial cell proliferation via changes in
TGF-/3 transcription. These findings are in contrast to the reports
of Lp(a) having a stimulatory effect on the proliferation of human
vascular smooth muscle cells [52].
The results of this study further clarify the role of receptor
mediated uptake of native and oxidized lipoproteins into mesan-
gial cells. Glomerular deposits are more likely to represent
matrix-bound but internalized Lp(a). With respect to the handling
of oxidized LDL by the mesangium, our findings contrast the
results obtained from studies with rat mesangial cells. Despite
poor uptake, Lp(a) and oxidized Lp(a) display antiproliferative
effects that are not mediated by changes in autocrine TGF-13
transcription.
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Appendix
Abbreviations are: apo, apolipoprotein; DMEM, Dulbecco's minimal
essential medium; FCS, fetal calf serum; LDL, low density lipoprotein;
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LDS, lipoprotein deficient serum; Lp(a), lipoprotein (a); PBS, phosphate
buffered saline; PDGF, platelet-derived growth factor; SDS-PAGE, so-
dium dodecyl sulfate polyacrylamide gel electrophoresis; TBARS, thio-
barbituric acid reactive substances; TCA, trichloric acid; TGF-J3, trans-
forming growth factor beta.
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